Notch1 expression is upregulated in glioma and is associated with tumor progression

Journal of Clinical Neuroscience

Volumn 18, Issue 3, 2011, Pages 387-390

  Jiang, Ligang ^a,b   Wu, Jie ^a   Chen, Qiuhui ^a   Hu, Xinyu ^a   Li, Wei ^c   Hu, Guohua ^a  

^a JILIN UNIVERSITY   (China)

^b Jilin Central Hospital   (China)

^c BEIHUA UNIVERSITY   (China)

Author keywords

Glioma; Notch1; Progression

Indexed keywords

NOTCH1 RECEPTOR;

ADULT; ARTICLE; FEMALE; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH; UPREGULATION; WESTERN BLOTTING;

BLOTTING, WESTERN; BRAIN NEOPLASMS; DISEASE PROGRESSION; FEMALE; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROGNOSIS; RECEPTOR, NOTCH1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 79551519193     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2010.07.131     Document Type: Article

References (19)

1. A. Jemal, R. Siegel, and E. Ward Cancer statistics, 2009 CA Cancer J Clin 59 2009 225 249
2. P. Kleihues, P.C. Burger, and B.W. Scheithauer The new WHO classification of brain tumours Brain Pathol 3 1993 255 268
3. D.N. Louis, H. Ohgaki, and O.D. Wiestler The 2007 WHO classification of tumours of the central nervous system Acta Neuropathol 114 2007 97 109
4. S.S. Stylli, M. Howes, and L. MacGregor Photodynamic therapy of brain tumours: evaluation of porphyrin uptake versus clinical outcome J Clin Neurosci 11 2004 584 596
5. S.S. Stylli, A.H. Kaye, and L. MacGregor Photodynamic therapy of high grade glioma: long term survival J Clin Neurosci 12 2005 389 398
6. S.S. Stylli, and A.H. Kaye Photodynamic therapy of cerebral glioma: a review. Part II: clinical studies J Clin Neurosci 13 2006 709 717
7. R. Stupp, W.P. Mason, and M.J. van den Bent Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 2005 987 996
8. E.G. Van Meir, C.G. Hadjipanayis, and A.D. Norden Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma CA Cancer J Clin 60 2010 166 193
9. A. Bigas, D.I. Martin, and L.A. Milner Notch1 and Notch2 inhibit myeloid differentiation in response to different cytokines Mol Cell Biol 18 1998 2324 2333
10. S. Artavanis-Tsakonas, M.D. Rand, and R.J. Lake Notch signaling: cell fate control and signal integration in development Science 284 1999 770 776
11. S. Weijzen, P. Rizzo, and M. Braid Activation of Notch1 signaling maintains the neoplastic phenotype in human Ras-transformed cells Nat Med 8 2002 979 986
12. M. Nicolas, A. Wolfer, and K. Raj Notch1 functions as a tumor suppressor in mouse skin Nat Genet 33 2003 416 421
13. V. Sriuranpong, M.W. Borges, and R.K. Ravi Notch signaling induces cell cycle arrest in small cell lung cancer cells Cancer Res 61 2001 3200 3205
14. A. Zlobin, M. Jang, and L. Miele Toward the rational design of cell fate modifiers: Notch signaling as a target for novel biopharmaceuticals Curr Pharm Biotechnol 1 2000 83 106
15. M.S. Jang, A. Zlobin, and W.M. Kast Notch signaling as a target in multimodality cancer therapy Curr Opin Mol Ther 2 2000 55 65
16. B.W. Purow, R.M. Haque, and M.W. Noel Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation Cancer Res 65 2005 2353 2363
17. A. Rhodes, B. Jasani, and D.M. Barnes Reliability of immunohistochemical demonstration of oestrogen receptors in routine practice: interlaboratory variance in the sensitivity of detection and evaluation of scoring systems J Clin Pathol 53 2000 125 130
18. M. Kogiku, I. Ohsawa, and K. Matsumoto Prognosis of glioma patients by combined immunostaining for survivin, Ki-67 and epidermal growth factor receptor J Clin Neurosci 15 2008 1198 1203
19. S.S. Stylli, A.H. Kaye, and P. Lock Invadopodia: at the cutting edge of tumour invasion J Clin Neurosci 15 2008 725 737